Study of SGB-3908 in Healthy Subjects and Mildly Hypertensive Subjects

NCT06501586 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension,Essential

Interventions

DRUG: SGB-3908
OTHER: SGB-3908-Matching placebo

Sponsor

Suzhou Sanegene Bio Inc.

Collaborators

[object Object]